SecurityCTSO / Cytosorbents Corp (23283X206)
IndustrySurgical and Medical Instruments and Apparatus
Common Shares Outstanding31,459,443 shares (as of 2018-06-30)
Total Insiders11
Total Directors6
Total Officers5

Stock Insider Trading (from SEC Form 4)

Cytosorbents Corp insider trades are listed in the following table, followed by a table containing the full transaction history. Insiders are officers, directors, or significant investors in a company. In general, it is generally illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.

CTSO / Cytosorbents Corp insiders include Mortensen Eric R. Capponi Vincent, Jones Edward Raymond, Gunton James T., Chan Phillip P., BATOR MICHAEL G., Sobel Alan D., NJTC INVESTMENT FUND, LP, and BLOCH KATHLEEN P., Kraus Al, BARTLETT ROBERT HAWES, .

Insider Roster

Insider Dir Off 10% Shares Owned
Chan Phillip P. President and CEO, Director
X X 438,281
Capponi Vincent Chief Operating Officer
X 332,768
Kraus Al Director
X 125,046
BLOCH KATHLEEN P. Chief Financial Officer
X 259,004
Sobel Alan D. Director
X 69,300
BATOR MICHAEL G. Director
X 73,800
Jones Edward Raymond Director
X 71,800
Mortensen Eric R. Chief Medical Officer
X 36,500
BARTLETT ROBERT HAWES Chief Medical Officer
X
NJTC INVESTMENT FUND, LP 10% Owner
X
Gunton James T. Director, 10% Owner
X X

Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b-5 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Form Insider Code 10b-5 Direct Share
Price
Shares
Changed
Remaining
Shares
Post Value
2018-09-07 4 Chan Phillip P. S D 14.11 -2,731 438,281 6,184,145
2018-09-07 4 Chan Phillip P. M D 2.10 2,731 449,699
2018-09-06 4 Chan Phillip P. S D 14.75 -2,900 441,012 6,504,927
2018-09-06 4 Chan Phillip P. M D 2.10 2,900 446,968
2018-09-05 4 Chan Phillip P. S D 14.85 -5,187 443,912 6,592,093
2018-09-05 4 Chan Phillip P. S D 14.85 -600 449,099 6,669,120
2018-09-05 4 Chan Phillip P. M D 2.10 5,187 444,068
2018-09-05 4 Chan Phillip P. M D 2.00 600 438,881
2018-08-30 4 Kraus Al S D 14.4724 -26,000 125,046 1,809,716
2018-08-30 4 Kraus Al M D 4.20 18,000 151,046
2018-08-30 4 Kraus Al M D 2.10 8,000 133,046
2018-08-29 4 Capponi Vincent S X D 14.00 -20,000 332,768 4,658,752
2018-08-29 4 Capponi Vincent M X D 3.45 20,000 352,768
2018-08-28 4 Capponi Vincent S X D 13.00 -9,565 332,768 4,325,984
2018-08-28 4 Capponi Vincent M X D 3.75 9,565 342,333
2018-08-28 4 BLOCH KATHLEEN P. S X D 13.50 -10,000 259,004 3,496,554
2018-08-28 4 BLOCH KATHLEEN P. M X D 2.875 10,000 269,004
2018-08-03 4 BLOCH KATHLEEN P. S X D 12.151 -3,600 259,004 3,147,158
2018-08-03 4 BLOCH KATHLEEN P. S X D 12.75 -6,200 262,604 3,348,201
2018-08-03 4 BLOCH KATHLEEN P. S X D 12.85 -200 268,804 3,454,131
2018-08-03 4 BLOCH KATHLEEN P. M X D 2.875 10,000 269,004
2018-08-03 4 Capponi Vincent S X D 13.08 -7,600 332,768 4,352,605
2018-08-03 4 Capponi Vincent M X D 3.45 7,600 340,368
2018-08-02 4 Capponi Vincent S X D 13.00 -2,835 332,768 4,325,984
2018-08-02 4 Capponi Vincent M X D 3.45 2,835 335,603
2018-06-15 4 Capponi Vincent F D 12.35 -15,215 332,768
2018-06-15 4 Capponi Vincent S X D 12.00 -8,633 347,983 4,175,796
2018-06-15 4 Capponi Vincent M D 0.875 40,000 367,983
2018-06-15 4 Capponi Vincent M X D 3.75 8,633 327,983
2018-06-14 4 Capponi Vincent S X D 12.00 -11,367 356,616 4,279,392
2018-06-14 4 Capponi Vincent M X D 3.75 11,367 319,350
2018-06-11 4 Chan Phillip P. X D 3.75 8,000 461,281
2018-05-16 4 Capponi Vincent S X D 9.00 -4,846 317,551 2,857,959
2018-05-16 4 Capponi Vincent M X D 0.875 4,846 322,397
2018-05-17 4 Capponi Vincent S X D 10.00 -20,000 317,551 3,175,510
2018-05-17 4 Capponi Vincent S X D 10.00 -8,000 337,551 3,375,510
2018-05-17 4 Capponi Vincent M X D 0.875 20,000 345,551
2018-05-17 4 Capponi Vincent M X D 4.20 8,000 325,551
2018-05-15 4 Capponi Vincent S X D 9.00 -3,154 317,551 2,857,959
2018-05-15 4 Capponi Vincent S X D 9.00 -4,000 320,705 2,886,345
2018-05-15 4 Capponi Vincent M X D 0.875 3,154 324,705
2018-05-15 4 Capponi Vincent M X D 4.20 4,000 321,551
2018-05-15 4 BLOCH KATHLEEN P. S X D 8.75 -12,400 262,304 2,295,160
2018-05-15 4 BLOCH KATHLEEN P. M X D 4.69 12,400 274,704
2018-05-16 4 BLOCH KATHLEEN P. S X D 9.00 -12,400 262,304 2,360,736
2018-05-16 4 BLOCH KATHLEEN P. M X D 4.69 12,400 274,704
2018-05-14 4 BLOCH KATHLEEN P. S X D 8.50 -10,000 262,304 2,229,584
2018-05-14 4 BLOCH KATHLEEN P. M X D 2.90 10,000 272,304
2018-03-15 4 Kraus Al A D 3,300 125,046
2018-03-15 4 Jones Edward Raymond A D 3,300 71,800
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)

Related News Stories

Cytosorbents Stock Could Score Big With Its Blood-Filtering Technology

2018-08-30 investorplace
Cytosorbents (NASDAQ:CTSO) is something of a hit in Europe but is virtually unknown in the U.S. (1-0)

Revisiting Cytosorbents

2018-08-12 seekingalpha
The stock of this name has almost tripled in the past year as investors have bid up this 'razor & razor blade' story. (1-0)

Cytosorbents' (CTSO) CEO Phillip Chan on Q2 2018 Results - Earnings Call Transcript

2018-08-04 seekingalpha
Good afternoon, and welcome to the Cytosorbents Second Quarter 2018 Financial and Operating Results Conference Call. [Operator Instructions] Please be advised that the call will be recorded at the company’s request. (1-2)

Cytosorbents' (CTSO) CEO Phillip Chan on Q1 2018 Results - Earnings Call Transcript

2018-05-12 seekingalpha
Good afternoon and welcome to the Cytosorbents' First Quarter 2018 financial and operating results conference call. At this time, all participants are in a listen-only mode. Following the formal remarks, we will open the call for your questions. Please be advised that the call will be recorded at the Company's request.